Pexastimogene devacirepvec
N/A
Report date: 2025/07/01 20:00:14
Base Information
Drug NamePexastimogene devacirepvec
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[18]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[17]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesSillajen IncRegeneron Pharmaceuticals IncNational Cancer Institute +[4]
China Registration ClassN/A
Develop Information
Active CompaniesTransgene SaInstitut BergoniéNational Cancer Institute +[5]
Inactive CompaniesOntario Institute For Cancer ResearchJennerex Biotherapeutics IncZhaoke Pharmaceutical (Hefei) Co Ltd
Active Indications +[6]
Inactive Indications +[12]